Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)
NCT05006235 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 135
Last updated 2021-08-16
Summary
Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn: Randomized controlled trial to assess:
Conditions
- Transient Tachypnea of the Newborn
Interventions
- DRUG
-
Epinephrine Inhalation Solution
- DRUG
-
Salbutamol
- DRUG
-
Saline Inhalants
Sponsors & Collaborators
-
Ahmed Noaman
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Hour
- Max Age
- 6 Hours
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-01
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
More Related Trials
-
the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
NCT05527704 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Inhaled Furosemide for Transient Tachypnea of Newborn
NCT04397991 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04264156 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness of Nebulized Hypertonic Saline and Epinephrine in Hospitalized Infants With Bronchiolitis
NCT01300325 ·Status: COMPLETED ·Phase: PHASE4
-
Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis
NCT01016249 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
NCT02150499 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants
NCT01748045 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure
NCT00922532 ·Status: WITHDRAWN ·Phase: PHASE3
-
Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children
NCT03814954 ·Status: COMPLETED ·Phase: NA
-
The Use of Nasal Phenylephrine in Infants With Bronchiolitis
NCT00373802 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Nitric Oxide by Oxygen Hood in Neonates
NCT00732537 ·Status: COMPLETED ·Phase: PHASE4
-
Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
NCT02528318 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)
NCT00685126 ·Status: COMPLETED ·Phase: PHASE3
-
Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.
NCT02586961 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
7% Hypertonic Saline for Acute Bronchiolitis
NCT01871857 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
NCT01220687 ·Status: COMPLETED ·Phase: NA
-
Status Asthmaticus on the PICU; Intravenous Salbutamol
NCT03493503 ·Status: COMPLETED ·Phase: PHASE4
-
Premedication for Non-Emergency Endotracheal Intubation In the NICU
NCT01749501 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis
NCT01238848 ·Status: COMPLETED ·Phase: NA
-
Hypertonic Saline for Acute Bronchiolitis
NCT01247064 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Bethanechol on Tracheobronchomalacia
NCT05299008 ·Status: RECRUITING
-
Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants
NCT00152542 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Efficacy of Hypertonic Saline vs Adrenaline Nebulization in Acute Bronchiolitis
NCT06267118 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis
NCT06139029 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Nebulized Hypertonic Saline Treatment in Hospitalized Children With Moderate to Severe Viral Bronchiolitis
NCT01120496 ·Status: COMPLETED ·Phase: NA